AzTrials
AzTrials

HypertensionNCT00207194

Interactive Multirisk-Factor Intervention for Hypertension (HTN) Blacks

A study testing Automated Telephone Program and Health Behavior Education in people with Hypertension, run by Boston Medical Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to assess the efficacy of Telephone-Linked_Care for Hypertension Regimen Adherence in an African American population (TLC-HTN-AA). TLC-HTN-AA is a computer-based telecommunication system that will monitor, educate and counsel African American adults with hypertension on adherence to… Read more about this study

Who is it for?
Ages 35 years and older
Conditions the study is for
Hypertension
What is being tested?
Automated Telephone Program and Health Behavior Education
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
337 participants
Where
1 siteUnited States
Study dates
Oct 2001to Aug 2007
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 35 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • a patient with a primary care provider at one of Boston Medical Center's Adult Primary Care Medical Practices or one of three HealthNet health centers participating in the study
  • have a physician diagnosis of hypertension
  • be African American by self-report
  • be 35 years of age or older
  • be prescribed at least one medication for hypertension
  • have poorly controlled blood pressure
Show all 9Show fewer
  • be non-adherent to at least one hypertensive medication
  • understand spoken English
  • have a home telephone

Who cannot join

  • patients for whom a medication, diet or exercise regiment adherence improvement or maintenance program would be inappropriate
  • patients with a terminal illness
  • patients with severe medical or psychiatric illness
  • patients with cognitive difficulty

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Medical Information Systems Unit/Boston Medical Center

    Boston, Massachusetts, 02118

Other trials in United States

About this study

Official title: Interactive Multirisk-Factor Intervention for HTN Blacks

The aim of this study is to assess the efficacy of Telephone-Linked_Care for Hypertension Regimen Adherence in an African American population (TLC-HTN-AA). TLC-HTN-AA is a computer-based telecommunication system that will monitor, educate and counsel African American adults with hypertension on adherence to medication, diet, and exercise. The primary hypotheses are:

  1. TLC-HTN-AA use will improve medication regiment adherence
  2. TLC-HTN-AA will improve adherence to 3 healthy diet recommendations
  3. TLC-HTN-AA will improve levels of regular exercise
  4. Patients receiving TLC-HTN-AA will be more likely to become adherent to all 3 target regiments than patients in the control group
Conditions
Hypertension
Being tested
Automated Telephone Program, Health Behavior Education
Medical subject headings
Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Automated Telephone ProgramBehavioural

    The intervention incorporated principles of social cognitive theory, the transtheoretical model of behavioral change, and motivational interviewing, and was tailored to the user's values. Content was also adapted to cultural characteristics of culturally African-American adults (i.e., not Caribbean-American, Black-Hispanic, etc.). These participants also received the same health behavior education those in the control condition received.

  • Health Behavior EducationBehavioural

    Participants received a 75-page resource manual that described hypertension, listed dietary recommendations, heart healthy food recipes, and local resources for exercise, and provided information to support antihypertensive medication adherence. They received a 20-min education session based on the content of this manual, and were given a pedometer and a digital weight scale (Healthometer, model # HDR900KD01).

Study groups in NCT00207194
Study groupRoleWhat they receive
Automated Telephone ProgramActive comparatorThe intervention was a totally automated, computer-based, interactive telephone counseling system called Telephone- Linked-Care, designed to monitor, educate, and counsel African-American adults with hypertension and to provide summary data regularly to the patient's primary care provider.
Receives: Behavioral: Automated Telephone Program; Behavioral: Health Behavior Education
Health Behavior EducationPlacebo comparatorThe comparator group received health education relating to the management of hypertension. Members of this group also received standard primary medical care.
Receives: Behavioral: Health Behavior Education

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 1-proportion of study subjects who achieve adequate adherence (greater than or equal to 80% of doses taken) at the end of the intervention period

    Outcomes were assessed at baseline, 4 months, 8 months (the end of the study intervention) and 12 months.

    Measured: 8 months

  2. 2-consumption of more than 5 servings of fruits and vegetables a day, less than 30% of calories from fat, and less than 2400 mg of sodium a day at the end of the intervention period

    Outcomes were assessed at baseline, 4 months, 8 months (the end of the study intervention) and 12 months.

    Measured: 8 months

  3. 3-adherence to CDC-ACSM recommendations for moderate intensity physical activity at the end of the intervention period

    Outcomes were assessed at baseline, 4 months, 8 months (the end of the study intervention) and 12 months.

    Measured: 8 months

Secondary outcomes (1)
  1. 1-TLC-HTN-AA use will reduce the mean blood pressure and the proportion of the treatment group having uncontrolled hypertension at the end of the intervention period

    Outcomes were assessed at baseline, 4 months, 8 months (the end of the study intervention) and 12 months.

    Measured: 8 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2005 (estimated)
  2. Study startOct 2001
  3. Primary completionAug 2007
  4. Study completionAug 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
337 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00207194
Sponsor's protocol ID
HL 69395
Status last verified
Jun 2016
First submitted
12 Sep 2005
Last updated
16 Jun 2016
Results posted
No
Data monitoring committee
Yes

Publications

  • Migneault JP, Dedier JJ, Wright JA, Heeren T, Campbell MK, Morisky DE, Rudd P, Friedman RH. A culturally adapted telecommunication system to improve physical activity, diet quality, and medication adherence among hypertensive African-Americans: a randomized controlled trial. Ann Behav Med. 2012 Feb;43(1):62-73. doi: 10.1007/s12160-011-9319-4.

    PubMed 22246660

Questions about this trial

What is this clinical trial studying?

A study testing Automated Telephone Program and Health Behavior Education in people with Hypertension, run by Boston Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

1-proportion of study subjects who achieve adequate adherence (greater than or equal to 80% of doses taken) at the end of the intervention period (time frame: 8 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00207194, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in